Chief, Human Immunological Diseases Section
NIH/NIAID
Bethesda, Maryland, United States
Helen Su received M.D. and Ph.D. degrees from Brown University. She completed training in pediatrics at St. Louis Children’s Hospital, Washington University, subspecialty training in allergy and immunology at NIAID, and postdoctoral training with Michael Lenardo, M.D. at the NIAID. She was tenured at the NIAID in the Laboratory of Host Defenses (now Laboratory of Clinical Immunology and Microbiology) in 2016. She is a recipient of the Society for Pediatric Research E. Mead Johnson Award and the Gale and Ira Drukier Prize in Children's Health Research. Her laboratory studies the molecular mechanisms of inherited human immunological diseases with a focus on host immunity to viruses, and has led discoveries into the understanding of human immunodeficiencies such as DOCK8 deficiency and MDA5 deficiency. More recently, as co-director of both the NIAID Immune Response to COVID-19 Consortium and the COVID Human Genetic Effort, she has also led international collaboration work focused on understanding host susceptibility factors contributing to severe SARS-CoV-2 infections.
Disclosure information not submitted.
Human Cytosolic Double-stranded RNA Sensors and SARS-COV-2 Susceptibility
Wednesday, June 19, 2024
1:00 PM – 1:25 PM PT
